Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-10

Clinical Trial Update: Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effects of liraglutide on cognitive function in patients with type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Third Military Medical University | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED